The catalysts over the next few months are probably all
The catalysts over the next few months are probably all being choreographed to fit into AMBS' master plan.
They have put their stake in the ground regarding LymPro Commercialization (December) and up listing. (NASDAQ in November or December). They've also pretty much put their stake in the ground regarding the one billion authorized shares and the diagnostic spin off. Huffman was probably brought on specifically to do this "financial engineering." Gerald's credibility is on the line. He has publicly stated these things in a way he can't back out now.
So we've had a couple days go by without earth shattering news. LOL! How immature shareholders and message board posters can be. (Me especially!) Gerald is moving mountains to transform AMBS and much of the message board conversation is about Gerald's lack of performance and credibility. I can't believe that. I could make a list of all the things I know AMBS is moving forward with that would blow your mind. I've done it before many times, and so have others. Gerald just might be up for the CEO of the Year Award if he pulls off HALF of what I think he is attempting! And, there is a lot he is doing that none of us even know anything about! This is an incredible company and Gerald is a miracle maker!
I am feel very good about what's going on. The last couple of day's lull in news means absolutely nothing! And those like Solantey that are making a big deal about it should be ashamed of themselves and banned immediately from this board!
I think the master plan calls for revenue guidance during the CC on Sept. 2nd. I think releasing the "bridge data" before that makes sense. I think announcing our LymPro partner in the first half of September also makes sense, before the Shareholder meeting on the 22nd. Also, the partner needs 3 months to perform their validation test in their lab. They need to start in mid Sept. to end by mid December. That's a fact!
We're close ladies and gentleman. Relax and let it unfold. Be careful about selling shares too cheaply. I've only been through what we're about to go through once. That stock went from $8 to $81 in 8 months! My only regret is that I sold too early. I started selling off in the high teens and was completely out by $38. When a company like AMBS takes off.....it's a real spectacle! Hang on to your shares.
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Strong Numbers, But There's More to Unpack Nine months into 2026, Classys Inc. ain't exactly putting up shabby numbers. They've rolled in with KRW 275.7 billion like it was a stroll in the park, marking a sturdy 13% jump from last year. Yet, with all this, their operating profit has taken a 9.4% spill. It's a mixed bag, folks, and Classys is gearing up for a massive...
Continue Reading
AI in Banking: Cautious Steps Forward Banks aren't exactly racing with AI; they're inching forward. With AI agents entering the picture, you'd think the buzz would be about groundbreaking deployments. Instead, the story here is more about banks holding their cards close to the vest. Agentic AI, with its ability to plan and act without a human babysitter at every step, is...
Continue Reading
WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...
Continue Reading
No one wants to deal with roof damage, but knowing the rules of the game is half the battle. The landscape of insurance claims can be tricky—especially when Mother Nature starts playing hard ball. Here, we break down what homeowners need to know to stay one step ahead in these situations. Unpacking Roof Damage Coverage Most homeowners think they've got things covered...
Continue Reading
Mark Your Calendars, Investors! Folks grumble about the mundane task of checking fiscal calendars, but without this intel, where are we? On November 17, 2026, Palatin Technologies (NASDAQ:PTN) is slated to release their Q1 Fiscal Year 2027 operating results bright and early, before most of us have even sipped our coffee. The buzz around these numbers is as electric as any...
Continue Reading
Boosting Midday Energy with BIBIBOP's New Promo Here we go, folks. BIBIBOP Asian Grill is dialing up the culinary energy just when you need it most. From November 16 to 22, during their Good Energy Happy Hour, they’re serving up a deal designed to pump some pep into your afternoon—free OLIPOP prebiotic soda with any regular bowl purchase. Just stroll into any of their...
Continue Reading
A Staggering Universe Deepens: Hutuo's Introduction Just when you think you've seen it all, NetEase Games and Everstone Studio go and launch Hutuo, a compelling addition to the already sprawling universe of Where Winds Meet. On the occasion of its first global anniversary, this epic Wuxia ARPG throws players into the mud-soaked, steel-clashing chaos of a warzone, testing...
Continue Reading
Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...
Continue Reading
Betting Big on Small Business If you've ever run a small business, you know it can feel like a hamster wheel—more customers usually mean more headaches. But here comes Worker.ai, stepping onto the scene with big promises and a fancy new acquisition. They've scooped up DeltaGen—a mover in real-time AI tech—and launched a platform to hand these overworked owners a...
Continue Reading
A Simpler Way to Bridge the Mac and Windows World Seems like Parallels Desktop is once again flexing its muscles for Mac users in 2026. Expert Consumers out of New York just gave them the thumbs-up as the go-to pick for folks wanting to hitch their Mac wagon to Windows 11. And why not? Parallels lets you take a stroll through Windows land without cutting your Mac ties. A...
Continue Reading
Top 5 Most Recently Viewed Articles
Hyzon Motors Raises $4.5 Million from Stock Sales Hyzon Motors Inc. (NASDAQ: HYZN), a pioneering company in the development of electric and hydrogen-powered industrial vehicles, has successfully secured approximately $4.5 million through the recent sale of its Class A common stock. This strategic move was executed on an "at-the-market" basis and involved Roth Capital...
Continue Reading
Exploring the Future of the Personal Care Emulsifiers Market The Personal Care Emulsifiers market is on a promising trajectory, expected to grow significantly in the coming years. According to recent research, the market, valued at around $1.5 billion in 2024, is projected to soar to $2.8 billion by 2034, at a compound annual growth rate (CAGR) of 6.5%. This growth...
Continue Reading
Assembly Neos clinched significant victories in the G2 Fall reports back in 2024, standing tall as a premier product in the Momentum Grid for Legal Case Management. Traders knew this wasn't just another accolade; it was a signal of strength in a market often filled with uncertainty and noise. Desks were buzzing—user satisfaction metrics placed Assembly Neos in the top...
Continue Reading
APA Corporation Announces Cash Dividend for Shareholders HOUSTON — The board members of APA Corporation (NASDAQ: APA) have exciting news for shareholders. They have declared a cash dividend on the company's common shares, reflecting their commitment to maximizing shareholder value. Details of the Dividend Payment This newly declared dividend amounts to a significant 25...
Continue Reading
Lennar Corporation Announced Exchange Offer Details Expecting Registration Statement Approval by Expiration Date MIAMI — Lennar Corporation (NYSE: LEN) and LEN.B, a leader in quality home construction, has confirmed the launch of an offer to exchange approximately 20% of its outstanding shares in Millrose Properties, Inc. (NYSE: MRP) for shares of Lennar's Class A...
Continue Reading